top of page

Bitemporal Hemianopia


History Taking

Chief Complaint:

  • Complaints of visual loss, usually peripheral vision

  • Difficulty in reading, driving, or navigating spaces

  • Bumping into objects

History of Presenting Complaint:

  • Noticing gaps or blind spots in the field of vision

  • Gradual, insidious onset

  • May have associated headaches

  • Often, visual disturbances are more pronounced in low light conditions

System Review:

  • Headache, particularly if persistent or worsening

  • Symptoms suggestive of pituitary dysfunction such as weight gain, lethargy, menstrual irregularities (due to pituitary adenoma)

  • Acromegalic features such as enlarged hands, feet, facial changes (due to growth hormone-secreting pituitary adenoma)

  • Symptoms of hyperthyroidism such as weight loss, palpitations, heat intolerance (due to TSH-secreting pituitary adenoma)

  • Symptoms of adrenal insufficiency like fatigue, weight loss, hypotension, salt craving (secondary to ACTH deficiency)

  • Galactorrhea, decreased libido, infertility (due to prolactin-secreting pituitary adenoma)

Past Medical History:

  • History of other visual disturbances or eye disease

  • History of endocrine disorders

  • History of neurological disorders or neurosurgical interventions

  • History of cranial radiation therapy

Past Surgical History:

  • History of brain or pituitary surgery

  • History of any radiation treatment

Drug History:

  • Use of medications such as corticosteroids which can affect the pituitary gland

  • Medications for existing endocrine disorders

Family History:

  • Family history of pituitary tumors or other endocrine disorders

  • Family history of visual disturbances or eye diseases

Personal History:

  • Any history of trauma or injury to the head or eyes

  • Exposure to radiation or toxic substances

Social History:

  • Impact of visual symptoms on daily activities, work, or driving

  • Support system available, especially if visual loss is significant

Physical Examination

General Examination:

  • Observe for acromegalic features (large hands and feet, coarse facial features, prominent jaw) indicative of a growth hormone-secreting pituitary adenoma

  • Look for signs of Cushing's syndrome such as central obesity, 'moon face', and 'buffalo hump', indicative of ACTH-secreting pituitary adenoma

  • Notice any signs of hypogonadism such as reduced body hair or gynecomastia in males, amenorrhea in females (due to pituitary adenoma)

Face (Eyes, Nose, Mouth):

  • Bitemporal hemianopia observed during visual field testing

  • Optic atrophy or papilledema on fundoscopy

Neurological Examination:

  • Assessment of visual acuity might show reduction

  • Assessment of visual fields will show loss of vision in the outer (temporal) half of both eyes

  • Cranial nerve examination is important, specifically cranial nerve II (optic nerve) for visual acuity, visual fields, color vision, and fundoscopy; and cranial nerve III (oculomotor nerve) for pupillary reactions and eye movements

  • Other cranial nerves may be affected, especially in larger lesions or with mass effect, so a full cranial nerve examination should be undertaken

Additional Examination if Required:

  • Endocrine assessment may be necessary if symptoms suggestive of hormonal hyper- or hyposecretion are present. This could include tests of thyroid, adrenal, and gonadal function

Investigations

Laboratory Tests:

  • Complete blood count: Can show anemia or other hematological abnormalities associated with some pituitary disorders

  • Serum prolactin: Elevated in prolactinomas

  • Serum growth hormone and insulin-like growth factor-1: Elevated in acromegaly

  • Serum TSH and free thyroxine: Assess thyroid function, could be abnormal in a TSH-secreting pituitary adenoma

  • Serum ACTH and cortisol: Assess adrenal function, could be abnormal in a ACTH-secreting pituitary adenoma

  • Serum FSH, LH, testosterone/estradiol: Assess gonadal function, could be abnormal in gonadotroph-secreting pituitary adenoma

Imaging Studies:

  • Magnetic Resonance Imaging (MRI) of the brain with contrast: Gold standard for visualizing pituitary tumors or other structural lesions causing the bitemporal hemianopia

  • Computed Tomography (CT) scan of the brain: If MRI is contraindicated or not available, a CT can provide some information, though it is less sensitive than MRI for detecting pituitary tumors

Invasive Tests:

  • Visual field testing (perimetry): Though technically non-invasive, this is a specific test to map the visual field loss in detail

  • Lumbar puncture: If there is concern about intracranial hypertension as a cause of papilledema

Other Tests:

  • Dynamic pituitary function tests: These can include tests like the dexamethasone suppression test or growth hormone suppression test, depending on the suspected pituitary disorder

Management

General Management:

  • Patient education about the nature of the disease and treatment options

  • Regular follow-ups for monitoring disease progression and treatment response

Medical Management:

  • Dopamine agonists like cabergoline or bromocriptine for prolactin-secreting adenomas

  • Somatostatin analogs (like octreotide) or growth hormone receptor antagonists (like pegvisomant) for growth hormone-secreting adenomas

  • Steroid replacement for ACTH deficiency, levothyroxine for TSH deficiency, sex hormone replacement for gonadotropin deficiency

  • For hormone secreting adenomas, medications to block the effects of excess hormones may be used (such as antithyroid drugs for a TSH-secreting adenoma)

Surgical Management:

  • Transsphenoidal surgery to remove the pituitary tumor is often the first-line treatment for larger or symptomatic tumors, especially if causing significant visual impairment

  • Craniotomy may be required for larger tumors or if transsphenoidal approach is not feasible

  • Radiotherapy (either conventional or stereotactic) may be used as adjunctive therapy after surgery, especially in tumors not completely removed or for non-resectable tumors

Other Management:

  • For visual symptoms, referral to an ophthalmologist for further management and regular visual field testing to monitor disease progression

  • For pituitary apoplexy (a rare but serious complication), urgent neurosurgical referral is required

  • Regular endocrinology follow-up for patients with residual pituitary function or requiring ongoing medical treatment for pituitary tumors

  • Psychosocial support and counselling as needed, given the chronic nature of the disease and potential impact on quality of life

  • Consideration of genetic counselling and screening for familial conditions in patients with certain types of pituitary tumors.


 
 
bottom of page